Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Gastroenterology

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2005.09.005PMID 16285943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of Stat3 Sequence-specific DNA Binding and Transcription by p300/CREB-binding Protein-mediated Acetylation*

  2005cited by this paper
• Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation

  2004cited by this paper
• A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation*

  2004cited by this paper
• Smad7 in TGF-β-mediated negative regulation of gut inflammation

  2004cited by this paper
• CBP and p300: HATs for different occasions.

  2004cited by this paper
• Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.

  2004cited by this paper
• New insights into TGF-β–Smad signalling

  2004cited by this paper
• New insights into TGF-beta-Smad signalling.

  2004cited by this paper
• Optimizing anti-TNF treatment in inflammatory bowel disease.

  2004cited by this paper
• Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.

  2004cited by this paper
• Smad7 in TGF-beta-mediated negative regulation of gut inflammation.

  2004cited by this paper
• Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

  2003cited by this paper
• Ubiquitin ligases and the immune response.

  2003cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper
• Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

  2003cited by this paper
• Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7

  2003cited by this paper
• p300 cooperates with Smad3/4 and Runx3 in TGFβ1‐induced IgA isotype expression

  2003cited by this paper
• Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

  2002cited by this paper
• Control of Smad7 stability by competition between acetylation and ubiquitination.

  2002cited by this paper
• Transforming growth factor signal transduction

  2002cited by this paper
• Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation*

  2001cited by this paper
• Regulatory T cells in the control of immune pathology

  2001cited by this paper
• Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

  2001cited by this paper
• p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2

  2001cited by this paper
• Acetylation of importin-alpha nuclear import factors by CBP/p300.

  2000cited by this paper
• Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators

  2000cited by this paper
• Acetylation of importin-α nuclear import factors by CBP/p300.

  2000cited by this paper
• Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.

  2000cited by this paper
• Effector and regulatory lymphoid cells and cytokines in mucosal sites.

  1999cited by this paper
• Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β

  1999cited by this paper
• Activation of nuclear factor κB in inflammatory bowel disease

  1998cited by this paper

• Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer

  2025cites this paper
• Amelioration of Ethanol-Induced Gastric Ulcer in Rats by Tilapia Skin Derived Collagen And/or Vitamin C: Implication of NFκB/TNFα and BAX/Bcl-2 Pathways

  2025cites this paper
• Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut.

  2024cites this paper
• Smad7 as a positive regulator of intestinal inflammatory diseases

  2023cites this paper
• The Role of TGF-β, Activin and Follistatin in Inflammatory Bowel Disease

  2023cites this paper
• N-Acetylglucosamine and its dimer ameliorate inflammation in murine colitis by strengthening the gut barrier function.

  2023cites this paper
• TGF‐β1 signaling and Smad7 control T‐cell responses in health and immune‐mediated disorders

  2023cites this paper
• FHL1 mediates HOXA10 deacetylation via SIRT2 to enhance blastocyst-epithelial adhesion

  2022cites this paper
• Deletion of Smad7 Ameliorates Intestinal Inflammation and Contributes to Fibrosis.

  2022cites this paper
• Emerging role of protein modification in inflammatory bowel disease

  2022cites this paper
• Molecular mechanism of the TGF-β/Smad7 signaling pathway in ulcerative colitis

  2022cites this paper
• Sam68 contributes to intestinal inflammation in experimental and human colitis

  2021cites this paper
• Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer

  2021influential citation
• Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases

  2020cites this paper
• Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

  2020cites this paper
• Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling

  2020cites this paper
• TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases.

  2020cites this paper
• Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn’s Disease

  2020cites this paper
• Current perspectives on inhibitory SMAD7 in health and disease

  2020cites this paper
• High Smad7 in the early post-operative recurrence of Crohn’s disease

  2020cites this paper
• A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn’s Disease

  2020cites this paper
• Immunomodulatory Effects of TGF-β Family Signaling within Intestinal Epithelial Cells and Carcinomas

  2019cites this paper
• Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis

  2019cites this paper
• Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity

  2019cites this paper
• Epigenetic Regulation of Intestinal Fibrosis

  2018cites this paper
• Reciprocal Regulation Between Smad7 and Sirt1 in the Gut

  2018cites this paper
• Immunotherapy in inflammatory bowel disease: Novel and emerging treatments

  2018cites this paper
• Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer

  2018cites this paper
• Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.

  2018cites this paper
• Role of SMAD proteins in colitis-associated cancer: from known to the unknown

  2018cites this paper
• Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

  2017cites this paper
• High Smad7 sustains inflammatory cytokine response in refractory coeliac disease

  2017cites this paper
• Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges

  2017cites this paper
• Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation

  2017cites this paper
• Smad7 as a Target for Immunomodulation Strategy in Inflammatory BowelDiseases

  2017cites this paper
• Therapeutic Targets in Inflammatory Bowel Disease: Current and Future

  2016cites this paper
• Genetic and epigenetic regulation of intestinal fibrosis

  2016cites this paper
• MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells

  2016cites this paper
• Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy

  2016cites this paper
• Mitigated NSAID-induced apoptotic and autophagic cell death with Smad7 overexpression

  2016cites this paper
• Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.

  2016cites this paper
• Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn’s disease

  2016cites this paper
• Over‐expression of prothymosin‐α antagonizes TGFβ signalling to promote the development of emphysema

  2016cites this paper
• Syddansk Universitet Lower Superoxide Dismutase 2 ( SOD 2 ) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy

  2016cites this paper
• Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

  2015cites this paper
• Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.

  2015cites this paper
• Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease

  2015cites this paper
• Heterogeneity of subordination of the IL-18/IFN-γ axis to caspase-1 among patients with Crohn’s disease

  2015cites this paper
• Harmful effect of oxysterols in the gut and at systemic level: modulatory activity of olive oil phenolics

  2015cites this paper
• The TGF-&bgr;/Smad System in IBD Pathogenesis

  2015cites this paper
• Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.

  2015cites this paper
• Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models

  2014cites this paper
• The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut.

  2014cites this paper
• Smad7 Sustains Inflammation in the Gut: From Bench to Bedside

  2014cites this paper
• Mechanisms That Mediate the Development of Fibrosis in Patients With Crohn's Disease

  2014cites this paper
• TGF-Beta signaling manipulation as potential therapy for IBD.

  2013cites this paper
• Dlg5 interacts with the TGF‐β receptor and promotes its degradation

  2013cites this paper
• Epigenetic and disease targets by polyphenols.

  2013cites this paper
• The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis

  2013cites this paper
• Bone morphogenetic proteins and signaling pathway in inflammatory bowel disease

  2012cites this paper
• Mechanisms and Consequences of Intestinal Inflammation

  2012cites this paper
• Leukocyte Function-associated Antigen-1/Intercellular Adhesion Molecule-1 Interaction Induces a Novel Genetic Signature Resulting in T-cells Refractory to Transforming Growth Factor-β Signaling*

  2012cites this paper
• Role of Smad7 in inflammatory bowel diseases.

  2012cites this paper
• Regulation of the transforming growth factor β pathway by reversible ubiquitylation

  2012cites this paper
• Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways.

  2011cites this paper
• A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population

  2011cites this paper
• The role of the IL23/IL17 pathway in inflammatory bowel disease

  2011cites this paper
• Superoxide dismutase type 1 in monocytes of chronic kidney disease patients

  2011cites this paper
• Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo

  2011cites this paper
• The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease.

  2011cites this paper
• Role of cannabinoid receptors and RAGE in inflammatory bowel disease.

  2011cites this paper
• Current state of Wilson disease patients in central Japan.

  2010cites this paper
• Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced IκBα Expression and NF-κB Inactivation

  2010cites this paper
• Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies

  2010cites this paper
• 17 Smad4/TGF-b Signaling Pathways in Pancreatic Cancer Pathogenesis

  2010cites this paper
• Role of transforming growth factor‐&bgr; in inflammatory bowel disease and colitis‐associated colon cancer

  2010cites this paper
• TGF-beta1 and IGF-1 production and recurrence of Crohn's disease after ileo-colonic resection.

  2009cites this paper
• Inflammatory bowel disease.

  2009cites this paper
• TGF-beta and fibrosis in different organs - molecular pathway imprints.

  2009cites this paper
• Targeting Smads to restore transforming growth factor-beta signaling and regulatory T-cell function in inflammatory bowel disease.

  2009cites this paper
• Regulating the stability of TGFβ receptors and Smads

  2009cites this paper
• Pancreatic Cancer: Translational Implications

  2009cites this paper
• Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1β and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease

  2009cites this paper
• Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.

  2009cites this paper
• High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD

  2009cites this paper
• Transcriptomic analysis of intestinal fibrosis‐associated gene expression in response to medical therapy in Crohn's disease

  2008cites this paper
• Cytokine network in rectal mucosa in perianal Crohn's disease: Relations with inflammatory parameters and need for surgery

  2008cites this paper
• TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection

  2008cites this paper
• Molecular interactions of commensal enteric bacteria with the intestinal epithelium and the mucosal immune system: implications for chronic intestinal inflammation.

  2008cites this paper
• Aberrant Transforming Growth Factor-β Signaling in Human Pancreatic Cancer: Translational Implications

  2008cites this paper
• Cytokine pathways in inflammatory bowel disease—the yin and the yang

  2008cites this paper
• To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

  2008cites this paper
• TGF-β1 and Smad7 in the regulation of IBD

  2008cites this paper
• Blockade of transforming growth factor β upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa

  2008cites this paper
• Bacteria‐ and host‐derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation

  2007cites this paper
• TGFβ1 expression in colonic mucosa: modulation by dietary lipids

  2007influential citation
• Current World Literature

  2007cites this paper
• Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms.

  2007cites this paper
• Negative regulation of TGF-beta receptor/Smad signal transduction.

  2007cites this paper
• Systematic Association Mapping Identifies NELL1 as a Novel IBD Disease Gene

  2007cites this paper